RET Cancer Research Takes Center Stage at ASCO, May 2026
The 2026 ASCO Annual Meeting 2026, taking place May 29–June 2 in Chicago, will feature…
Irene Guijarro MunozMay 15, 2026
Don’t Miss Together Separately, presented by LCRF and the Susan Wojcicki Foundation on May 14th, 2026
Join the special edition of Together Separately, presented by LCRF and the Susan Wojcicki Foundation…
Irene Guijarro MunozApril 30, 2026
New Global Findings from the RETgistry: Advancing Care for RET-Altered Cancers
The RETgistry study looked at tumor samples from biopsies of RET patients whose cancers stopped…
Irene Guijarro MunozApril 7, 2026
The Future of RET Therapy for NSCLC (2026 TTLC Meeting)
The IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) Meeting was held on February 18th. The meeting…
Irene Guijarro MunozMarch 26, 2026
Q&A from the 2025 RET Lung Cancer Annual Webinar
Expert answers to your most pressing questions about RET-positive cancer from our scientists and pharmaceutical…
Irene Guijarro MunozMarch 24, 2026
Finding the Right RET Oncologist for Your Cancer Treatment
Finding the right oncologist and medical care team is one of the most important decisions…
Irene Guijarro MunozFebruary 13, 2026
Announcing the Lung Cancer Genetics Study Database
A cancer diagnosis can be life-altering but with access to high-quality, compassionate care, patients can…
Irene Guijarro MunozSeptember 11, 2025
Home Health Care: Bringing Cancer Care Home
A cancer diagnosis can be life-altering but with access to high-quality, compassionate care, patients can…
Irene Guijarro MunozAugust 11, 2025
Stronger Together: Our RET-Positive Lung Cancer Partners
Collaboration is at the heart of progress in the fight against RET-positive lung cancer. Each…
Irene Guijarro MunozFebruary 16, 2025
Breaking Ground: The Most Successful Treatment Options for RET-Positive Lung Cancer
Discover the most effective RET cancer treatment options available today, their benefits, and what to…
Irene Guijarro MunozJanuary 27, 2025
